Gene · 10020
Papers4,261
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,261
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of Brain Pathologies on Spatiotemporal Gait Parameters in Patients with Mild Cognitive Impairment. | J Alzheimers Dis | 2023 | 37742636 | PubTator, text mining | PubMed |
| What makes joint assessment procedures attractive to the innovative industry: successes, challenges, and proposed improvements. | Front Med (Lausanne) | 2023 | 37731723 | PubTator, text mining | PubMed |
| C-Myc-induced hypersialylation of small cell lung cancer facilitates pro-tumoral phenotypes of macrophages. | iScience | 2023 | 37731607 | PubTator, text mining | PubMed |
| SEPepQuant enhances the detection of possible isoform regulations in shotgun proteomics. | Nat Commun | 2023 | 37726316 | PubTator, text mining | PubMed |
| Dynein-Powered Cell Locomotion Guides Metastasis of Breast Cancer. | Adv Sci (Weinh) | 2023 | 37726225 | PubTator, text mining | PubMed |
| Progress in nanoparticle-based regulation of immune cells. | Med Rev (2021) | 2023 | 37724086 | PubTator, text mining | PubMed |
| WHO guideline on the use of non-sugar sweeteners: a need for reconsideration. | Eur J Clin Nutr | 2023 | 37723261 | PubTator, text mining | PubMed |
| Genes selection using deep learning and explainable artificial intelligence for chronic lymphocytic leukemia predicting the need and time to therapy. | Front Oncol | 2023 | 37719021 | PubTator, text mining | PubMed |
| Development of a sensitive microplate assay for characterizing RNA methyltransferase activity: Implications for epitranscriptomics and drug development. | J Biol Chem | 2023 | 37716702 | PubTator, text mining | PubMed |
| A Case Report of Cardiofaciocutaneous Syndrome with MAP2K1 Pathogenic Variant. | Pharmgenomics Pers Med | 2023 | 37705935 | PubTator, text mining | PubMed |
| Tomosyn affects dense core vesicle composition but not exocytosis in mammalian neurons. | Elife | 2023 | 37695731 | PubTator, text mining | PubMed |
| Formulation and Characterization of Mupirocin Nanomicelles in Insulin-Based Gel for Dermatological Application. | J Pharm Bioallied Sci | 2023 | 37694028 | PubTator, text mining | PubMed |
| Epidermolysis Bullosa Simplex With Dystonin Gene Mutation: First Reported Case in Saudi Arabia. | Cureus | 2023 | 37692655 | PubTator, text mining | PubMed |
| Combined sequence and copy number analysis improves diagnosis of limb girdle and other myopathies. | Ann Clin Transl Neurol | 2023 | 37688281 | PubTator, text mining | PubMed |
| Engineered Biomaterials Trigger Remineralization and Antimicrobial Effects for Dental Caries Restoration. | Molecules | 2023 | 37687202 | PubTator, text mining | PubMed |
| Gut, oral, and nasopharyngeal microbiota dynamics in the clinical course of hospitalized infants with respiratory syncytial virus bronchiolitis. | Front Cell Infect Microbiol | 2023 | 37680746 | PubTator, text mining | PubMed |
| The Triglyceride-Glucose Index is Independently Associated with Chronic Kidney Disease in the Geriatric Population, Regardless of Obesity and Sex. | Ann Geriatr Med Res | 2023 | 37673691 | PubTator, text mining | PubMed |
| At-home use of parasacral transcutaneous electrical nerve stimulation for pediatric voiding dysfunction: a randomized controlled trial to assess its safety and feasibility. | Front Pediatr | 2023 | 37670742 | PubTator, text mining | PubMed |
| A patient-derived organoid-based study identified an ASO targeting SNORD14E for endometrial cancer through reducing aberrant FOXM1 Expression and β-catenin nuclear accumulation. | J Exp Clin Cancer Res | 2023 | 37667311 | PubTator, text mining | PubMed |
| GNE myopathy: can homozygous asymptomatic subjects give a clue for the identification of protective factors? | Neuromuscul Disord | 2023 | 37666692 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10020/papers?page=14